These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19773439)

  • 1. c-Myc and eIF4F constitute a feedforward loop that regulates cell growth: implications for anticancer therapy.
    Lin CJ; Malina A; Pelletier J
    Cancer Res; 2009 Oct; 69(19):7491-4. PubMed ID: 19773439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Myc and eIF4F are components of a feedforward loop that links transcription and translation.
    Lin CJ; Cencic R; Mills JR; Robert F; Pelletier J
    Cancer Res; 2008 Jul; 68(13):5326-34. PubMed ID: 18593934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Myc oncoprotein as a therapeutic target for human cancer.
    Vita M; Henriksson M
    Semin Cancer Biol; 2006 Aug; 16(4):318-30. PubMed ID: 16934487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the eIF4F translation initiation complex for cancer therapy.
    Konicek BW; Dumstorf CA; Graff JR
    Cell Cycle; 2008 Aug; 7(16):2466-71. PubMed ID: 18719377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of c-Myc/Max dimerization and DNA binding by small molecules.
    Kiessling A; Sperl B; Hollis A; Eick D; Berg T
    Chem Biol; 2006 Jul; 13(7):745-51. PubMed ID: 16873022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Of Myc and Mnt.
    Hooker CW; Hurlin PJ
    J Cell Sci; 2006 Jan; 119(Pt 2):208-16. PubMed ID: 16410546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer therapeutics: targeting the dark side of Myc.
    Ponzielli R; Katz S; Barsyte-Lovejoy D; Penn LZ
    Eur J Cancer; 2005 Nov; 41(16):2485-501. PubMed ID: 16243519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting synthetic lethal interactions between Myc and the eIF4F complex impedes tumorigenesis.
    Lin CJ; Nasr Z; Premsrirut PK; Porco JA; Hippo Y; Lowe SW; Pelletier J
    Cell Rep; 2012 Apr; 1(4):325-33. PubMed ID: 22573234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational control of cell fate: from integration of environmental signals to breaching anticancer defense.
    Bitterman PB; Polunovsky VA
    Cell Cycle; 2012 Mar; 11(6):1097-107. PubMed ID: 22356766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL5 promotes proliferation of MCF-7 cells through mTOR-dependent mRNA translation.
    Murooka TT; Rahbar R; Fish EN
    Biochem Biophys Res Commun; 2009 Sep; 387(2):381-6. PubMed ID: 19607806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunomodulatory benzodiazepine Bz-423 inhibits B-cell proliferation by targeting c-myc protein for rapid and specific degradation.
    Sundberg TB; Ney GM; Subramanian C; Opipari AW; Glick GD
    Cancer Res; 2006 Feb; 66(3):1775-82. PubMed ID: 16452238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The eukaryotic initiation factor 4E-binding proteins and apoptosis.
    Proud CG
    Cell Death Differ; 2005 Jun; 12(6):541-6. PubMed ID: 15818413
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeting the eIF4F translation initiation complex: a critical nexus for cancer development.
    Pelletier J; Graff J; Ruggero D; Sonenberg N
    Cancer Res; 2015 Jan; 75(2):250-63. PubMed ID: 25593033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing anti-neoplastic biotherapeutics against eIF4F.
    Steinberger J; Chu J; Maïga RI; Sleiman K; Pelletier J
    Cell Mol Life Sci; 2017 May; 74(9):1681-1692. PubMed ID: 28004147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Max homodimeric b-HLH-LZ significantly interferes with the specific heterodimerization between the c-Myc and Max b-HLH-LZ in absence of DNA: a quantitative analysis.
    McDuff FO; Naud JF; Montagne M; Sauvé S; Lavigne P
    J Mol Recognit; 2009; 22(4):261-9. PubMed ID: 19189276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Pathways: The eIF4F Translation Initiation Complex-New Opportunities for Cancer Treatment.
    Malka-Mahieu H; Newman M; Désaubry L; Robert C; Vagner S
    Clin Cancer Res; 2017 Jan; 23(1):21-25. PubMed ID: 27789529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myc, cell competition, and compensatory proliferation.
    Gallant P
    Cancer Res; 2005 Aug; 65(15):6485-7. PubMed ID: 16061622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Myc-anisms for DNA replication and tumorigenesis?
    Lebofsky R; Walter JC
    Cancer Cell; 2007 Aug; 12(2):102-3. PubMed ID: 17692801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acting locally and globally: Myc's ever-expanding roles on chromatin.
    Varlakhanova NV; Knoepfler PS
    Cancer Res; 2009 Oct; 69(19):7487-90. PubMed ID: 19773445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of cancer cell metabolism: oncogenic MYC in the driver's seat.
    Dong Y; Tu R; Liu H; Qing G
    Signal Transduct Target Ther; 2020 Jul; 5(1):124. PubMed ID: 32651356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.